These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15791891)

  • 21. Cardiovascular protection paradigms: is change on the horizon?
    Papademetriou V
    Rev Cardiovasc Med; 2007; 8(4):200-13. PubMed ID: 18192943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of quality of dietary fat on serum cholesterol and coronary heart disease: focus on plant sterols and other non-glyceride components.
    Ghafoorunissa
    Natl Med J India; 2009; 22(3):126-32. PubMed ID: 19764688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lowering cholesterol: how low is low enough?].
    Czuriga I; Edes I
    Orv Hetil; 2006 Jul; 147(29):1349-56. PubMed ID: 16941825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Summary of 'Cholesterol' guideline (first revision) of the Dutch Society of Family Physicians].
    van der Laan JR; Thomas S
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):421-7. PubMed ID: 10719546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The innocence and culpability of cholesterol (I)].
    Nau JY
    Rev Med Suisse; 2007 Jun; 3(117):1658. PubMed ID: 17708238
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetics and molecular biology: rationale for targeting high-density lipoprotein cholesterol for therapeutic intervention.
    Mukherjee S
    Curr Opin Lipidol; 2006 Oct; 17(5):602-5. PubMed ID: 16960508
    [No Abstract]   [Full Text] [Related]  

  • 29. Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk.
    Brown BG; Zhao XQ
    Am J Cardiol; 2008 Apr; 101(8A):58B-62B. PubMed ID: 18375243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part VI--The recent rise and fall of the HDL-boosting drug torceptrapib.
    Moyad MA; Merrick GS
    Urol Nurs; 2007 Apr; 27(2):169-73. PubMed ID: 17494462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum cholesterol and coronary heart disease: Auckland general practitioners' attitudes and practices in 1986.
    Yates K; Jackson R; Tester P; Thompson A; Toledo J; Vamanamurthy R; Wong C
    N Z Med J; 1988 Feb; 101(840):76-8. PubMed ID: 3380436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypercholesterolemia and cardiovascular risk: advantages and limitations of current treatment options].
    Cimminiello C; Zambon A; Polo Friz H
    G Ital Cardiol (Rome); 2016 Apr; 17(4 Suppl 1):6S-13. PubMed ID: 27312018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of children with hypercholesterolemia].
    Girardet JP
    Arch Pediatr; 2006 Jan; 13(1):104-10. PubMed ID: 16257193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Women, the media, and heart disease. For better or for worse?
    Savoie I; Kazanjian A; Brunger F
    Int J Technol Assess Health Care; 1999; 15(4):729-37. PubMed ID: 10645114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholesterol reduction therapy: a double-edged knife.
    Ong HT
    Med J Malaysia; 1993 Jun; 48(2):107-12. PubMed ID: 8350783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration.
    Blanco-Colio LM; Martín-Ventura JL; de Teresa E; Farsang C; Gaw A; Gensini G; Leiter LA; Langer A; Martineau P; Egido J;
    Am Heart J; 2007 May; 153(5):881-8. PubMed ID: 17452168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 2006 Sep; 150(39):2127-30. PubMed ID: 17059084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.